CD33 and acute lymphoblastic leukemia: Therefore, these nine genes (KIT, PROM1, ANPEP, CD33, CDH2, CXCL2, HGF, NT5E, and IL1B) were selected as candidate diagnostic biomarkers of ETP-ALL.